Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe website footer/version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe study location entry was updated from Napoli, Italy to Naples, Italy. This aligns the listing with English-language naming conventions and improves readability of the site.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision: v3.5.0 implemented, replacing the previous v3.4.3. No visible changes to the study details or pages were detected.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded Primary peritoneal carcinoma and Fallopian tube cancer to the study conditions, and updated the page to revision v3.4.2.SummaryDifference0.3%

Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.